https://www.selleckchem.com/pr....oducts/monocrotaline
Segmental gastrectomy, a type of function-preserving surgery, is not broadly studied but can improve postoperative function and quality of life among patients with gastric cancer (GC). To establish an indication for middle segmental gastrectomy (MSG) as a treatment for middle-body (M and high-body (H GC. This cohort study analyzed patients with GC undergoing surgery between January 2000 and December 2015 in the National Cancer Center, Goyang, Korea, a high-volume cancer center with a structured database and accurate long-term